Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.37 |
| ▸ | PDK2 | Q15119 | 2/20 | 0.35 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.33 |
| ▸ | HSD11B1 | P28845 | 3/20 | 0.33 |
| ▸ | EDNRB | P24530 | 1/20 | 0.32 |
| ▸ | EDNRA | P25101 | 1/20 | 0.32 |
| ▸ | PTGS2 | P35354 | 2/20 | 0.31 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.31 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.31 |
| ▸ | HTR1A | P08908 | 2/20 | 0.30 |
| ▸ | HTR7 | P34969 | 2/20 | 0.30 |
| ▸ | BCL2 | P10415 | 1/20 | 0.30 |
| ▸ | BAK1 | Q16611 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL23318635 | 0.99 | SLC6A3 (0.38) | SLC6A3PDK2CYP1A2HSD11B1EDNRB | |
| SCHEMBL23609833 | 0.91 | PDK2 (0.40) | SLC6A3PDK2HSD11B1EDNRBEDNRA | |
| SCHEMBL23395063 | 0.89 | SLC6A3 (0.34) | SLC6A3PDK2 | |
| SCHEMBL23609300 | 0.88 | PDK2 (0.35) | SLC6A3PDK2HSD11B1EDNRBEDNRA | |
| SCHEMBL23609948 | 0.86 | SLC6A3 (0.35) | SLC6A3PDK2HSD11B1ALDH1A1HTR1A | |
| SCHEMBL25962015 | 0.86 | SLC6A3 (0.38) | SLC6A3PDK2HSD11B1PTGS2ALDH1A1 | |
| SCHEMBL23318634 | 0.85 | HSD11B1 (0.38) | PDK2HSD11B1ALDH1A1HTR1AHTR7 | |
| SCHEMBL22797277 | 0.85 | PDK2 (0.34) | PDK2ALDH1A1 | |
| SCHEMBL23318754 | 0.83 | PDK2 (0.32) | PDK2 | |
| SCHEMBL23318641 | 0.83 | PDK2 (0.32) | SLC6A3PDK2HSD11B1ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20210130313-A1 | NITROGEN-CONTAINING COMPOUND, ELECTRONIC COMPONENT AND ELECTRONIC DEVICE | SHAANXI LIGHTE OPTOELECTRONICS MATERIAL CO. LTD. (CN) | 2021-05-06 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210130313-A1 | NITROGEN-CONTAINING COMPOUND, ELECTRONIC COMPONENT AND ELECTRONIC DEVICE | EXOC1, NPM1, EXOC4 | SLC6A3 2771/4885PDK2 3410/4885CYP1A2 1328/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.